Last week the US Healthcare Sector hit new multi-year highs relative to the S&P500.

The Relative Strength has already been there under the surface.

And when you look at Healthcare on an absolute basis you can see the sideways digestion of prior gains during a period where most stocks and indexes were falling:

The largest insider transaction on today’s list is a Form 4 filing by Nimish P. Shah, who reported a purchase of roughly $5.1 million of Tricida $TCDA.

Thomas Meth, the president of Enviva $EVA, reported a purchase of 8,600 shares, equivalent to $505,508 worth of stock.

Nifty Auto has been attracting all the attention with the strength that it is displaying. Today we're here to share a long idea from the same sector.

From the desk of Steve Strazza @Sstrazza

Our International Hall of Famers list is composed of the 100 largest US-listed international stocks, or ADRs. We’ve also sprinkled in some of the largest ADRs from countries that did not make the market-cap cut. 

These stocks range from some well-known mega-cap multinationals such as Toyota Motor and Royal Dutch Shell to some large-cap global disruptors such as Sea Ltd and Shopify.

It’s got all the big names and more--but only those that are based outside the US. You can find all the largest US stocks on our original Hall of Famers list.

The beauty of these scans is really in their simplicity.

We take the largest names each week and then apply technical filters in a way that the strongest stocks with the most momentum rise to the top.

Based on the market environment, we can also flip the scan on its head and filter for weakness.

Let’s dive in and take a look at some of the most important stocks from around the world.

Here’s this week’s list:

We debuted a new scan recently which goes by the name- All Star Momentum.

All Star Momentum is a brand new scan that guides us towards the very best stocks in the market. We have incorporated our stock universe of Nifty 500 as the base this time around. Among the 500 stocks that we follow, this scan will pump out names that are most likely to outperform the market.

The largest insider buy on today’s list is a Form 4 filing by Turtle Creek Asset Management, which revealed a 496,000-share purchase of JELD-WEN Holding $JELD.

In his latest Form 4, the chairman and CEO of Enviva $EVA revealed a purchase of approximately $1 million in the lumber and wood company.

Monday night we held our June Monthly Conference Call, which Premium Members can access and rewatch here.

In this post, we’ll do our best to summarize it by highlighting five of the most important charts and/or themes we covered, along with commentary on each.

Let’s get right into it!

The largest insider buy on today’s list is a Form 4 filing by Michael Gladstone, independent director at Day One Biopharmaceuticals $DAWN.

Gladstone disclosed the purchase of approximately $11.5 million worth of shares in the mid-cap biotech company.

Do you remember 2017?

The memes going around those days were about how many days it had been since the S&P500 fell by over 1%.

Volatility was non-existent.

And this was hilarious to me, of course, living in California at the time and people freaking out about the Trump victory at the end of 2016.

With sentiment down in the dumps entering 2017, that sparked one of the greatest return / least volatile years on record.

In fact, 2017 had only 8 trading days on which the S&P500 was +/- 1%.

Every month so far this year has had at least that many:

From the desk of Steve Strazza @Sstrazza

Welcome to the 2 to 100 Club.

As many of you know, something we've been working on internally is using various bottom-up tools and scans to complement our top-down approach. It's really been working for us!

One way we're doing this is by identifying the strongest growth stocks as they climb the market-cap ladder from small- to mid- to large- and, ultimately, to mega-cap status (over $200B).

Once they graduate from small-cap to mid-cap status (over $2B), they come on our radar. Likewise, when they surpass the roughly $30B mark, they roll off our list.

But the scan doesn't just end there.

We only want to look at the strongest growth industries in the market, as that is typically where these potential 50-baggers come from.

This is the video recording of our June 22, 2022, Inside Scoop Weekly Strategy Session.

SkyKnight Capital Fund disclosed the purchase of approximately $1.6 million worth of shares in the home medical equipment company AdaptHealth Corp $AHCO, as it continues to build a position in the stock.

The fund now owns 8,906,070 shares, which represents a roughly 6.15% ownership stake in the medical devices company.